CDA | Evidence Driven
CDA | Evidence Driven

Route of Administration of Sufentanil and Fentanyl for Patients in Palliative Care

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1245-000
Effective finish date:

Question

  1. What is the clinical effectiveness of administering synthetic opioids (i.e., fentanyl, sufentanil) subcutaneously versus sublingually or intranasally for patients in palliative care?
  2. What is the clinical effectiveness of administering synthetic opioids (i.e., fentanyl, sufentanil) sublingually versus intranasally for patients in palliative care?
  3. What are the evidence-based guidelines regarding the route of administration for synthetic opioids (i.e., fentanyl, sufentanil) for patients in palliative care?

Key Message

We did not find any studies about the clinical effectiveness of administering synthetic opioids (i.e., fentanyl, sufentanil) subcutaneously versus sublingually or intranasally for patients in palliative care.

We found 2 non-randomized studies about the clinical effectiveness of administering synthetic opioids (i.e., fentanyl, sufentanil) sublingually versus intranasally for patients in palliative care.

We did not find any evidence-based guidelines about the route of administration for synthetic opioids (i.e., fentanyl, sufentanil) for patients in palliative care.

Files

Route of Administration of Sufentanil and Fentanyl for Patients in Palliative C… View PDF
Last Updated : December 16, 2022